ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0090

110 Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Rheumatology Disease Unit: Fracture, Neuropathy, and Pernicious Anemia Are Clues to Recognition

Michael Lovy1 and Andrew Dulalia1, 1Desert Oasis Healthcare, Palm Springs, CA

Meeting: ACR Convergence 2020

Keywords: Fracture, immunology, Miscellaneous Rheumatic and Inflammatory Diseases, neurology, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Monoclonal gammopathy of undetermined significance (MGUS) has been associated with osteoporosis, neuropathy, pernicious anemia, and low vitamin B12, and may precede multiple myeloma and lymphoplasmacytic disorders.  The purpose of this study is to determine the characteristics of a group of MGUS patients diagnosed in an outpatient rheumatology disease unit.

Methods: A retrospective chart review was conducted of patients found to have MGUS, including history and physical, laboratory and x-ray studies.  Patients were excluded if they had a preexisting lymphoproliferative disorder, if myeloma was subsequently diagnosed, or a repeat immunofixation did not show a paraprotein.

Results: There were 39 males and 71 females, ranging in age from 31 to 101 (mean 77 years).  The reasons for referral included subacute fracture of spine or pelvis-59, osteoporosis evaluation-11, inflammatory arthritis-16, degenerative and crystal induced arthritis-20, neuropathy-1, and abnormal laboratory result-3. Preexisting conditions included:  history of solid tumor-29, previous major osteoporotic fracture-63, hepatitis C-4,, RA-7, SLE-3, Sjogren’s-2, ulcerative colitis-3, thyroid disease-17, myasthenia gravis-1, and primary biliary cirrhosis-1. Neuropathy defined by a sensory loss above the ankle was found in 66 patients.  Paraprotein was identified by serum immunofixation in 93 patients:  IgG 68 %, IgM 18%, IgA-14% with 56 % lambda and 44% kappa chains.  Serum protein electrophoresis failed to show M-spike in 20 of these patients.  Light chains only were found among the remaining 17 patients; 3 kappa and 14 lambda.  Urine immunofixation was positive in 32 out of 77 tested.  Among the neuropathy patients,14 had IgM, 37 IgG, 4 IgA paraprotein, 8 lambda only and 3 kappa only light chains.  Pernicious anemia was diagnosed in 15 patients based on low vitamin B12 levels and the presence of either intrinsic factor or anti-parietal cell antibody.  79 of the 110 patients had either osteoporotic fracture, neuropathy, or PA.  Upon follow up one lupus patient was subsequently diagnosed with plasmablastic lymphoma and the one patient referred for neuropathy was diagnosed with follicular lymphoma

Conclusion: Rheumatologists will most likely encounter MGUS among patients evaluated for osteoporosis.  Neuropathy, pernicious anemia, and previous fracture should prompt investigation with immunofixation as a screening test.  If a MGUS is found and work up for myeloma is negative, studies for lymphoproliferative disorder should be considered in at risk patients.


Disclosure: M. Lovy, None; A. Dulalia, None.

To cite this abstract in AMA style:

Lovy M, Dulalia A. 110 Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Rheumatology Disease Unit: Fracture, Neuropathy, and Pernicious Anemia Are Clues to Recognition [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/110-patients-with-monoclonal-gammopathy-of-undetermined-significance-mgus-in-a-rheumatology-disease-unit-fracture-neuropathy-and-pernicious-anemia-are-clues-to-recognition/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/110-patients-with-monoclonal-gammopathy-of-undetermined-significance-mgus-in-a-rheumatology-disease-unit-fracture-neuropathy-and-pernicious-anemia-are-clues-to-recognition/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology